Aquatic Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-703
| Closed | -$75.3K | – | 1467 |
|
|
2024
Q4 | $75.3K | Sell |
703
-197
| -22% | -$21.1K | ﹤0.01% | 1116 |
|
|
2024
Q3 | $90.1K | Sell |
900
-900
| -50% | -$90.1K | ﹤0.01% | 936 |
|
|
2024
Q2 | $152K | Sell |
1,800
-3,200
| -64% | -$270K | 0.01% | 816 |
|
|
2024
Q1 | $366K | Buy |
+5,000
| New | +$366K | 0.01% | 625 |
|
|
2023
Q4 | – | Sell |
-100
| Closed | -$6K | – | 1495 |
|
|
2023
Q3 | $6K | Buy |
+100
| New | +$6K | ﹤0.01% | 1158 |
|
|
2023
Q2 | – | Sell |
-2,700
| Closed | -$199K | – | 1568 |
|
|
2023
Q1 | $199K | Sell |
2,700
-9,000
| -77% | -$663K | 0.01% | 585 |
|
|
2022
Q4 | $781K | Sell |
11,700
-2,406
| -17% | -$161K | 0.06% | 386 |
|
|
2022
Q3 | $758K | Buy |
+14,106
| New | +$758K | 0.07% | 318 |
|
|
2022
Q1 | – | Sell |
-802
| Closed | -$77K | – | 1314 |
|
|
2021
Q4 | $77K | Buy |
+802
| New | +$77K | 0.15% | 180 |
|